RAPPORT
Live / Allowed — Fifth extension granted (statement of use) (as of 25 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Oct 2022 filing date already counts against anyone who files later.
Record
- Serial number
- 97630353
- Mark type
- Word mark
- Filed
- 13 Oct 2022
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Keith Toms, Esq.
Goods and services
- Class 001 — Chemicals: Biological preparations for scientific purposes for use in targeting AMPA receptors
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; chemical and biochemical preparations and substances for medical purposes for treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; biological preparations for the treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders; chemical and biochemical preparations for medical purposes for use in targeting AMPA receptors; pharmaceutical preparations for use in targeting AMPA receptors; biological preparations for medical purposes for use in targeting AMPA receptors
- Class 040 — Treatment of materials: Custom manufacture of biochemical systems in the nature of pharmaceuticals, namely, custom manufacture of systems for targeting AMPA receptors; custom manufacturing for others, namely, manufacturing of pharmaceutical preparations for the treatment of neurological disorders, pain, acoustic trauma, epilepsy, seizures, and mood disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of neurologic disorders; pharmaceutical drug development services; scientific research; pharmaceutical research services; research and development in the pharmaceutical and biotechnology fields; providing information in the fields of research on neurologic disorders, drug development, research on pharmaceuticals and biotechnology
- Class 044 — Medical, beauty and agricultural services: Providing information in the fields of treatment of neurologic disorders and treatments involving pharmaceuticals
Owner
- Rapport Therapeutics, Inc., Boston, MA, US
- Rapport Therapeutics, Inc., Boston, MA, US
Prosecution history
- 26 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Sept 2026 — SOU EXTENSION 5 GRANTED
- 10 Aug 2026 — SOU EXTENSION 5 FILED
- 25 Sept 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 10 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 10 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2026 — SOU EXTENSION 4 GRANTED
- 28 Jan 2026 — SOU EXTENSION 4 FILED
- 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED